Announcements, News
Aterian Investment Partners Acquires Contract Pharmaceuticals Limited
New York and Miami, June 6, 2024 – Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has closed its acquisition of Contract Pharmaceuticals Limited Canada (“CPL” or the “Company”), a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms. […]
Announcements
CPL COMPLETES SUCCESSFUL REGULATORY INSPECTION FROM HEALTH CANADA
April 04, 2024 – Mississauga, Ontario. CPL, a leading contract development and manufacturing organization (CDMO) of non-sterile liquid and topical drug products, recently completed a successful inspection of its Mississauga production facility by Health Canada. Health Canada performed a routine inspection of CPL’s Danbro facility which includes the GMP manufacturing, packaging, and warehousing areas. Following the inspection, […]
Announcements
Aterian Investment Partners to Recapitalize CPL, a Leading Pharmaceutical Contract Development and Manufacturing Organization
New York and Miami, April 1, 2024 – Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has entered into an agreement to recapitalize Contract Pharmaceuticals Limited Canada (“CPL” or the “Company”), a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid […]
Announcements, News
CONTRACT PHARMACEUTICALS LIMITED (CPL) WELCOMES LUCY ZHAO AS MANAGER OF THE SKIN LAB
June 13, 2023 – Mississauga, Ontario. CPL, a leading contract development and manufacturing organization (CDMO) of non-sterile liquid and topical drug products, is thrilled to welcome Lucy Zhao as the Manager of the Skin Lab within our Product Development Services team. With a career spanning over 15 years, Lucy brings an impressive track record of success […]
Announcements, News
CPL Completes Successful Regulatory Inspections from Canadian and Brazilian Health Agencies
May 19, 2023 – Mississauga, Ontario. CPL, a leading contract development and manufacturing organization (CDMO) of non-sterile liquid and topical drug products, recently completed successful inspections of its Mississauga facilities by both the Brazilian Regulatory Authority (ANVISA) and Health Canada. Health Canada performed a routine inspection of CPL’s Meadowpine facility which includes the Quality Control analytical testing […]
Announcements, News
Contract Pharmaceuticals Limited appoints Jan Sahai as Chief Executive Officer
Press Release Mississauga, Ontario, January 18, 2023 – The Board of Directors of Contract Pharmaceuticals Limited (CPL) is pleased to appoint Jan Sahai, MBA, PharmD as Chief Executive Officer, effective immediately, reporting to Caitlin Wege, Executive Chair, Board of Directors. Since joining CPL in 2005 as head of business development, Jan has grown our […]